Replies to post #2444 on GenVec Inc (fka GNVC)

[EDHustle]

GNVC TNFerade is still in the Clinical trial stage Phase III PACT Study. the 184th event data results are pending Late March/Early April. The study is not expected to end til the 276 event. For further information on The PACT Study go to the Company website.

[DewDiligence]

You can’t get FDA approval to market a drug until you’ve submitted an application.